NSE Circulars (2169)
National Stock Exchange of India circulars including trading guidelines, compliance requirements, market operations updates, and regulatory changes affecting market participants.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSE announces relocation of its Chennai Common Investor Services Centre to a new address at Manapakkam effective December 01, 2025. | |||||||||||||||
NSE announces relocation of its Chennai Common Investor Services Centre to a new address at Manapakkam effective December 01, 2025.
| |||||||||||||||
Discontinuation of Interim Penalty Procedure for Ban Period Position Increases in Equity Derivatives NSE Clearing discontinues interim penalty procedure for position increases during ban period effective December 6, 2025, reverting to … | |||||||||||||||
NSE Clearing discontinues interim penalty procedure for position increases during ban period effective December 6, 2025, reverting to standard penalty provisions outlined in September 2025 circular.
| |||||||||||||||
NSE implements Enhanced Surveillance Measure changes affecting multiple securities, shifting them to Trade-for-Trade segment with 100% … | |||||||||||||||
NSE implements Enhanced Surveillance Measure changes affecting multiple securities, shifting them to Trade-for-Trade segment with 100% margin requirement effective December 01, 2025.
| |||||||||||||||
Paushak Limited's equity shares admitted to trading on NSE Capital Market segment effective December 01, 2025 with symbol PAUSHAKLTD. | |||||||||||||||
Paushak Limited's equity shares admitted to trading on NSE Capital Market segment effective December 01, 2025 with symbol PAUSHAKLTD.
| |||||||||||||||
NSE notifies the listing of Sudeep Pharma Limited equity shares with effect from November 28, 2025, following IPO at issue price of Rs. 593 … | |||||||||||||||
NSE notifies the listing of Sudeep Pharma Limited equity shares with effect from November 28, 2025, following IPO at issue price of Rs. 593 per share.
| |||||||||||||||
NSE announces the forthcoming listing of Sudeep Pharma Limited equity shares on the exchange with symbol SUDEEPPHRM and ISIN INE0QPI01025. | |||||||||||||||
NSE announces the forthcoming listing of Sudeep Pharma Limited equity shares on the exchange with symbol SUDEEPPHRM and ISIN INE0QPI01025.
| |||||||||||||||
NSE announces listing of further equity shares issued under ESOP schemes by 15 companies including Aditya Infotech, DOMS Industries, … | |||||||||||||||
NSE announces listing of further equity shares issued under ESOP schemes by 15 companies including Aditya Infotech, DOMS Industries, Brainbees Solutions, and others, effective November 28, 2025.
| |||||||||||||||
NSE announces listing of 327,265 equity shares of C2C Advanced Systems Limited issued under preferential allotment on SME EMERGE platform … | |||||||||||||||
NSE announces listing of 327,265 equity shares of C2C Advanced Systems Limited issued under preferential allotment on SME EMERGE platform effective November 28, 2025.
| |||||||||||||||
ECL Finance Limited's non-convertible debentures to be listed on NSE capital market segment from December 01, 2025, pursuant to transfer … | |||||||||||||||
ECL Finance Limited's non-convertible debentures to be listed on NSE capital market segment from December 01, 2025, pursuant to transfer from Edelweiss Retail Finance Limited through Scheme of Arrangement.
| |||||||||||||||
NSE announces the listing of privately placed debt securities from Axis Bank Limited, Cholamandalam Investment and Finance Company Limited, … | |||||||||||||||
NSE announces the listing of privately placed debt securities from Axis Bank Limited, Cholamandalam Investment and Finance Company Limited, and Sundaram Finance Limited on the capital market segment, effective November 28, 2025.
| |||||||||||||||